Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 205

    1.

    Frequency of the G/G genotype of resistin single nucleotide polymorphism at -420 appears to be increased in younger-onset type 2 diabetes.

    Ochi M, Osawa H, Hirota Y, Hara K, Tabara Y, Tokuyama Y, Shimizu I, Kanatsuka A, Fujii Y, Ohashi J, Miki T, Nakamura N, Kadowaki T, Itakura M, Kasuga M, Makino H.

    Diabetes. 2007 Nov;56(11):2834-8. Epub 2007 Aug 13.PMID: 17698599 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Plasma resistin, associated with single nucleotide polymorphism -420, is correlated with insulin resistance, lower HDL cholesterol, and high-sensitivity C-reactive protein in the Japanese general population.

    Osawa H, Tabara Y, Kawamoto R, Ohashi J, Ochi M, Onuma H, Nishida W, Yamada K, Nakura J, Kohara K, Miki T, Makino H.

    Diabetes Care. 2007 Jun;30(6):1501-6. Epub 2007 Mar 23.PMID: 17384338 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    The absence of evidence for major effects of the frequent SNP +299G>A in the resistin gene on susceptibility to insulin resistance syndrome associated with Japanese type 2 diabetes.

    Ochi M, Osawa H, Onuma H, Murakami A, Nishimiya T, Shimada F, Kato K, Shimizu I, Shishino K, Murase M, Fujii Y, Ohashi J, Makino H.

    Diabetes Res Clin Pract. 2003 Sep;61(3):191-8.PMID: 12965109 [PubMed - indexed for MEDLINE]Related articles

    4.

    The G/G genotype of a resistin single-nucleotide polymorphism at -420 increases type 2 diabetes mellitus susceptibility by inducing promoter activity through specific binding of Sp1/3.

    Osawa H, Yamada K, Onuma H, Murakami A, Ochi M, Kawata H, Nishimiya T, Niiya T, Shimizu I, Nishida W, Hashiramoto M, Kanatsuka A, Fujii Y, Ohashi J, Makino H.

    Am J Hum Genet. 2004 Oct;75(4):678-86. Epub 2004 Aug 26.PMID: 15338456 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Resistin polymorphisms are associated with cerebrovascular disease in Finnish Type 2 diabetic patients.

    Kunnari A, Ukkola O, Kesäniemi YA.

    Diabet Med. 2005 May;22(5):583-9.PMID: 15842513 [PubMed - indexed for MEDLINE]Related articles

    6.

    Resistin gene 3'-untranslated region +62G-->A polymorphism is associated with hypertension but not diabetes mellitus type 2 in a German population.

    Gouni-Berthold I, Giannakidou E, Faust M, Kratzsch J, Berthold HK, Krone W.

    J Intern Med. 2005 Dec;258(6):518-26.PMID: 16313475 [PubMed - indexed for MEDLINE]Related articles

    7.

    PPARgamma Pro12Ala Pro/Pro and resistin SNP-420 G/G genotypes are synergistically associated with plasma resistin in the Japanese general population.

    Osawa H, Tabara Y, Kawamoto R, Ohashi J, Ochi M, Onuma H, Nishida W, Yamada K, Nakura J, Miki T, Makino H, Kohara K.

    Clin Endocrinol (Oxf). 2009 Sep;71(3):341-5. Epub 2008 Oct 30.PMID: 19178525 [PubMed - indexed for MEDLINE]Related articles

    8.

    Variation in the resistin gene is associated with obesity and insulin-related phenotypes in Finnish subjects.

    Conneely KN, Silander K, Scott LJ, Mohlke KL, Lazaridis KN, Valle TT, Tuomilehto J, Bergman RN, Watanabe RM, Buchanan TA, Collins FS, Boehnke M.

    Diabetologia. 2004 Oct;47(10):1782-8. Epub 2004 Oct 27.PMID: 15517149 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Polymorphism in resistin promoter region at -420 determines the serum resistin levels and may be a risk marker of stroke in Japanese type 2 diabetic patients.

    Tsukahara T, Nakashima E, Watarai A, Hamada Y, Naruse K, Kamiya H, Nakamura N, Kato N, Hamajima N, Sekido Y, Niwa T, Tomita M, Oiso Y, Nakamura J.

    Diabetes Res Clin Pract. 2009 May;84(2):179-86. Epub 2009 Mar 6.PMID: 19269054 [PubMed - indexed for MEDLINE]Related articles

    10.

    Association of CTLA-4 gene A/G polymorphism in Japanese type 1 diabetic patients with younger age of onset and autoimmune thyroid disease.

    Takara M, Komiya I, Kinjo Y, Tomoyose T, Yamashiro S, Akamine H, Masuda M, Takasu N.

    Diabetes Care. 2000 Jul;23(7):975-8.PMID: 10895849 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Effect of the -420C/G variant of the resistin gene promoter on metabolic syndrome, obesity, myocardial infarction and kidney dysfunction.

    Norata GD, Ongari M, Garlaschelli K, Tibolla G, Grigore L, Raselli S, Vettoretti S, Baragetti I, Noto D, Cefalù AB, Buccianti G, Averna M, Catapano AL.

    J Intern Med. 2007 Jul;262(1):104-12.PMID: 17598818 [PubMed - indexed for MEDLINE]Related articles

    12.

    [Role of resistin in insulin resistance]

    Onuma H, Osawa H, Makino H.

    Rinsho Byori. 2008 Aug;56(8):698-704. Review. Japanese. PMID: 18800626 [PubMed - indexed for MEDLINE]Related articles

    13.

    Common genetic polymorphisms in the promoter of resistin gene are major determinants of plasma resistin concentrations in humans.

    Cho YM, Youn BS, Chung SS, Kim KW, Lee HK, Yu KY, Park HJ, Shin HD, Park KS.

    Diabetologia. 2004 Mar;47(3):559-65. Epub 2004 Jan 23. Erratum in: Diabetologia. 2004 Jul;47(7):1337-8. PMID: 14740159 [PubMed - indexed for MEDLINE]Related articles

    14.

    Resistin SNP-420 determines its monocyte mRNA and serum levels inducing type 2 diabetes.

    Osawa H, Onuma H, Ochi M, Murakami A, Yamauchi J, Takasuka T, Tanabe F, Shimizu I, Kato K, Nishida W, Yamada K, Tabara Y, Yasukawa M, Fujii Y, Ohashi J, Miki T, Makino H.

    Biochem Biophys Res Commun. 2005 Sep 23;335(2):596-602.PMID: 16087164 [PubMed - indexed for MEDLINE]Related articles

    15.

    Single nucleotide polymorphism (D68D, T to C) in the syntaxin 1A gene correlates to age at onset and insulin requirement in Type II diabetic patients.

    Tsunoda K, Sanke T, Nakagawa T, Furuta H, Nanjo K.

    Diabetologia. 2001 Nov;44(11):2092-7.PMID: 11719842 [PubMed - indexed for MEDLINE]Related articles

    16.

    Association of variants in RETN with plasma resistin levels and diabetes-related traits in the Framingham Offspring Study.

    Hivert MF, Manning AK, McAteer JB, Dupuis J, Fox CS, Cupples LA, Meigs JB, Florez JC.

    Diabetes. 2009 Mar;58(3):750-6. Epub 2008 Dec 15.PMID: 19074981 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Genetic variants at the resistin locus are associated with the plasma resistin concentration and cardiovascular risk factors.

    Ukkola O, Kunnari A, Kesäniemi YA.

    Regul Pept. 2008 Aug 7;149(1-3):56-9. Epub 2008 Mar 25.PMID: 18440081 [PubMed - indexed for MEDLINE]Related articles

    18.

    Genetic similarities between latent autoimmune diabetes in adults, type 1 diabetes, and type 2 diabetes.

    Cervin C, Lyssenko V, Bakhtadze E, Lindholm E, Nilsson P, Tuomi T, Cilio CM, Groop L.

    Diabetes. 2008 May;57(5):1433-7. Epub 2008 Feb 29.PMID: 18310307 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    The G/G genotype of a single nucleotide polymorphism at -1066 of c-Jun N-terminal kinase 1 gene (MAPK8) does not affect type 2 diabetes susceptibility despite the specific binding of AP2alpha.

    Osawa H, Yamada K, Tabara Y, Ochi M, Onuma H, Nishida W, Shimizu I, Kawamoto R, Fujii Y, Miki T, Ohashi J, Makino H.

    Clin Endocrinol (Oxf). 2008 Jul;69(1):36-44. Epub 2008 Jul 1.PMID: 18036196 [PubMed - indexed for MEDLINE]Related articles

    20.

    Serum resistin is positively correlated with the accumulation of metabolic syndrome factors in type 2 diabetes.

    Osawa H, Ochi M, Tabara Y, Kato K, Yamauchi J, Takata Y, Nishida W, Onuma H, Shimizu I, Fujii Y, Miki T, Ohashi J, Makino H.

    Clin Endocrinol (Oxf). 2008 Jul;69(1):74-80. Epub 2008 Jul 1.PMID: 18081734 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data